Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,772 results for "Product Liability Law & Strategy"...

The Complications of Full Disclosure
November 25, 2013
When does disclosure to the government potentially waive the attorney-client privilege or work product protection, and is the risk of waiver worth the disclosure?
Software Maker Files Appeal in Batman Film Trademark Suit
November 02, 2013
Software company Fortres Grand is pressing to revive its trademark infringement claims against Warner Bros. Entertainment Inc. for using the name of the real-life "Clean Slate" computer program in the Batman movie <i>The Dark Knight Rises</i> .
Making Your Firm More Productive
November 02, 2013
Owners and partners at law firms must learn more about the commercial realities of competition, pay attention to client retention, counter the increased security risks to private data on the cloud and understand how technology can reduce operating costs.
Establishing Copyright Damages When A Party Moves for Summary Judgment
November 02, 2013
Section 504(b) of the Copyright Act allows a copyright owner to obtain both the owner's actual damages as well as an infringer's profits attributable to the infringed work that weren't included in the actual damages award. What are the burdens of proof when a copyright infringement plaintiff seeks this recovery after a pre-trial summary judgment motion has been filed? How does an expert's report work into this? These issues were recently examined in the U.S. Court of Appeals for the Fourth Circuit.
The Media
October 31, 2013
While the media creates the impression of an out-of-control tort system, this is out of alignment with actual jury behavior.
Practice Tip: Why Product Manufacturers Should Heed Privacy Trends
October 31, 2013
A recent jury verdict and consumer survey indicates that privacy is touchstone issue for a majority of consumers.
What Remains of CE-Style Insurance Neutrality After GIT?
October 31, 2013
Among the most hard-fought battles involving insurers, policyholders, and asbestos claimants are those that have played out in courts called upon to review orders confirming plans of reorganization in asbestos bankruptcies.
Liabilities
October 31, 2013
This article is the seventh installment in an ongoing series focusing on accounting and financial matters for corporate counsel
From A to ZIP Codes, and Beyond
October 31, 2013
An ever-increasing number of companies find themselves facing potential liability for the use, collection, or release of consumer data -- including ZIP Codes.
When Med Mal and Mass Tort Claims Overlap
October 30, 2013
Med Mal defense attorneys must also be aware of the potential overlap between malpractice claims and mass tort claims.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›